Vancomycin, Gentamycin in Infective Endocarditis

NCT03688659 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-09-28

No results posted yet for this study

Summary

Infective endocarditis is a microbial infection of the endocardial surface of the heart.

Conditions

  • Infective Endocarditis

Interventions

DRUG

Vancomycin and gentamycin

intravenous

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Week
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-01-01
Completion
2021-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03688659 on ClinicalTrials.gov